563: Real-life initiation of elexacaftor/ivacaftor/tezacaftor in cystic fibrosis patients with severe lung disease
| Autor: | Kos, R., Neerincx, A., Brinkman, P., Lub, R., Vonk, S., Roukema, J., Reijers, M., Terheggen-Lagro, S., Altenburg, J., Majoor, C., Bos, L., Haarman, E., Maitland-Van der Zee, A. |
|---|---|
| Zdroj: | In Journal of Cystic Fibrosis November 2021 20 Supplement 2:S265-S266 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect